• 제목/요약/키워드: Carcinoma anaplastic

검색결과 56건 처리시간 0.029초

Clinicopathological Profile of Head and Neck Cancers in the Western Development Region, Nepal: A 4-Year Snapshot

  • Lasrado, Savita;Prabhu, Prashanth;Kakria, Anjali;Kanchan, Tanuj;Pant, Sadip;Sathian, Brijesh;Gangadharan, P.;Binu, V.S.;Arathisenthil, S.V.;Jeergal, Prabhakar A.;Luis, Neil A.;Menezes, Ritesh G.
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권12호
    • /
    • pp.6059-6062
    • /
    • 2012
  • Regional cancer epidemiology is an important basis for determining the priorities for cancer control in different countries worldwide. There is no reliable information about the pattern of head and neck cancer in western Nepal and hence an attempt was here made to evaluate the situation based on hospital data, which provide the only source in the western region of Nepal. A clinicopathological analysis of head and neck cancers treated between 2003 and 2006 in Manipal Teaching Hospital affiliated to Manipal College of Medical Sciences, Pokhara, Western Development Region, Nepal was performed. A total of 105 head and neck cancer cases were identified with a male to female ratio of 1.8:1. The median ages of male and female patients were 62 and 64 years, respectively. Ninety-seven (92.4%) of the cancer patients were suffering from carcinoma, three (2.9%) had blastoma, three (2.9%) had sarcoma, and two (1.9%) had lymphoma. The majority (61.9%) of carcinoma cases were squamous cell carcinoma followed by anaplastic carcinoma (7.2%). Of the carcinoma cases, the most common site of primary lesion was larynx (19.6%), followed by the thyroid (14.4%), the tongue and hypopharynx with 10.3% cases each. Comparative analysis among males and females did not reveal any sex difference in type of head and neck cancers. The head and neck cancer pattern revealed by the present study provides valuable leads to cancer epidemiology in western Nepal and useful information for health planning and cancer control, and future research in western Nepal.

햄스터 oval cell의 간흡충감염 후 담관암으로의 분화에 관한 세포병리학적 연구 (Cholangiocarcinogenesis Following Oval Cell Induction and Clonorchis sinensis Infestation in Hamster)

  • 윤병일;김방현;김대용
    • 한국수의병리학회지
    • /
    • 제6권1호
    • /
    • pp.41-48
    • /
    • 2002
  • Oval cell is considered as facultative precursor cells for both hepatocytes and biliary cells, as well as origin of hepatocellar and cholangiocellular carcinoma (CCC) during carcinogenesis or toxic liver injury. To clarify the cellular origin or differentiation of cholagiocarcinogensis, the fate of carcinogen-induced oval cells was pathologically and phenotypically chased in Syrian golden hamster liver after Clonorchis sinensis (CS) infection which would give rise to a promoting effect. Two week treatment of hamsters with 0.005% diethylnitrosamine (DEN) followed by 2 week treatment of 1% 2-acetylaminofluorene (AAF) under choline deficient diet resulted in massive proliferation of BrdU labeleed and PCNA positive oval cells showing various distinct morphology, histochemical and immunohistochemical phenotypes for GGT, cytokeratin 19 and OV-6. Oval cells also frequently form ductular-like structures or phenotypically show hepatocyte-like characteristics. After CS infection, the oval cells showed sequential morphological changes to atypicl proliferating bile ductules and all hamsters thereafter developed well differentiated and anaplastic CCC at 16 week after CS infection. In electron microscopy, some bile ductules were constructed by intermediate oval cells and bile ductular cells surrounded by basement membrane. The results of this study strongly suggest that CCC developed in the present study were originated from hepatic stem-like oval cells, supporting the theory of stem cell origin of cancers. In addition, this hamster model would be valuable for the molecular mechanistic study during chemical-triggered cholangiocarcinogenesis.

  • PDF

분화성 갑상선암의 방사성옥소 치료 (Radioiodine Therapy For Differentiatd Thyroid Cancer)

  • 홍성운
    • 대한핵의학회지
    • /
    • 제34권4호
    • /
    • pp.265-275
    • /
    • 2000
  • The thyroid gland is an interesting endocrine organ where a spectrum of tumors with different behavior arise. At one end of spectrum there is differentiated thyroid carcinoma (DTC) with excellent prognosis, whereas at the other end of the spectrum is anaplastic thyroid cancer which has universally poor outcome. Radioiodine (I-131) therapy has been in use for the treatment of thyroid diseases since 1946. It was introduced by Seidlin et al. 1) Although the use of I-131 has been vouge for a long time, its use in therapy for well differentiated thyroid cancer is still controversial 2). This is because, thyroid cancers (TC) are generally slow growing tumors, with low mortality and normal spans of survival. To record recurrence and mortality, long term follow up studies over a period of two to three decades are needed to establish definite conclusions on the acceptable mode of treatment The incidence of the disease being very low a large number of cases needed to establish a meaningful statistical data is lacking as most published reports feat with small series. Here again in the problem encountered are the differing protocols for treatment with I-131, the indications for treatment which may include or exclude ablation of residual thyroid tissue, cervical nodal and distal metastases. The dosage of I-131 used for ablation of residual thyroid tissue and metastatic disease also vary. The most reliable conclusion regarding I-131 treatment are obtained from studies reported on a large series of patients followed over a period of 2 decades or more from a single institute with a more or less unchanged protocol of management.

  • PDF

개 담관세포암(膽管細胞癌)의 1예(例) (A Case of Canine Cholangiocarcinoma)

  • 조성환;김덕환;김교준;권오덕;박노태
    • 농업과학연구
    • /
    • 제13권2호
    • /
    • pp.311-317
    • /
    • 1986
  • 식욕부진(食慾不振) 및 복부팽만(腹部膨滿)을 충남대학교(忠南大學校) 농과대학부속가축병원(農科大學部屬家畜病院)에 의뢰(依賴)된 11년(年)된 암컷 잡종견(雜種犬)을 병리조직학적(病理組織學的)으로 관찰(觀察)한 바 담관세포암으로 진단(診斷)하였고 그 결과(結果)는 다음과 같다. 임상적(臨床的) 소견(所見)으로 복부팽만(腹部膨滿), 식욕부진(食慾不振), 호흡곤란(呼吸困難), 및 침울(沈鬱) 등(等)을 관찰(觀察)할 수 있었고, 혈중(血中) GOT, GPT, LDH 및 BUN등(等)은 정상치(正常値)보다 증가(增加)하였으며 총단백량 및 Albumin 은 약간 감소(減少)하였다. 육안적(肉眼的) 소견(所見)으로 간장(肝臟)은 종대, 표면(表面)에는 많은 백색(白色)의 꽃양배추양 결절(結節)이 있었으며 직경(直徑) 3~4cm의 낭형성(囊形成)이 있었다. 낭내(囊內)에는 황백색(黃白色)의 교상물질(膠狀物質)이 차 있었다. 해부학적(解剖學的)으로 본종양을 간내(肝內) 담관암으로 분류(分類)하였다. 조직학적(組織學的)으로 본종양은 관상암과 담관낭종암이 혼합(混合)되어 있었으며 관상암은 관상구조(管狀構造)가 특징(特徵)으로 내피세포(內皮細胞)는 입방형(立方形) 또는 원계형(圓桂形)이며 결합조직(結合組織)의 증식(增殖)을 볼 수 있었다. 그리고 담관낭종암은 단층(單層)및 중층입방형(中層立方形) 또는 국주형세포(國柱形細胞)로 덮혀 있었다.

  • PDF

Long-term Surgical Outcomes in Oligometastatic Non-small Cell Lung Cancer: A Single-Center Study

  • Seungmo Yoo;Won Chul Cho;Geun Dong Lee;Sehoon Choi;Hyeong Ryul Kim;Yong-Hee Kim;Dong Kwan Kim;Seung-Il Park;Jae Kwang Yun
    • Journal of Chest Surgery
    • /
    • 제56권1호
    • /
    • pp.25-32
    • /
    • 2023
  • Background: We reviewed the clinical outcomes of patients with oligometastatic (OM) non-small cell lung cancer (NSCLC) who received multimodal therapy including lung surgery. Methods: We retrospectively analyzed 117 patients with OM NSCLC who underwent complete resection of the primary tumor from 2014 to 2017. Results: The median follow-up duration was 2.91 years (95% confidence interval, 1.48-5.84 years). The patients included 73 men (62.4%), and 76 patients (64.9%) were under the age of 65 years. Based on histology, 97 adenocarcinomas and 14 squamous cell carcinomas were included. Biomarker analysis revealed that 53 patients tested positive for epidermal growth factor receptor, anaplastic lymphoma kinase, or ROS1 mutations, while 36 patients tested negative. Metastases were detected in the brain in 74 patients, the adrenal glands in 12 patients, bone in 5 patients, vertebrae in 4 patients, and other locations in 12 patients. Radiation therapy for organ metastasis was performed in 81 patients and surgical resection in 27 patients. The 1-year overall survival (OS) rate in these patients was 82.8%, and the 3- and 5-year OS rates were 52.6% and 37.2%, respectively. Patients with positive biomarker test results had 1-, 3-, and 5-year OS rates of 98%, 64%, and 42.7%, respectively. These patients had better OS than those with negative biomarker test results (p=0.031). Patients aged ≤65 years and those with pT1-2 cancers also showed better survival (both p=0.008). Conclusion: Surgical resection of primary lung cancer is a viable treatment option for selected patients with OM NSCLC in the context of multimodal therapy.